Faculty profile

Joel Livingston

Back to faculty

Assistant ProfessorPediatrics DeptUniversity of Alberta

Joel Livingston

Assistant Professor

Pediatrics Dept

Faculty of Medicine & Dentistry

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
10 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Alberta profile.

Latest papers

Early venous thrombus resolution in neonates/infants: retrospective review of a 20-year single institution experience.
Research and practice in thrombosis and haemostasis · 2026 · senior author
Critical bleeding in adults and children with immune thrombocytopenia: a multicenter cohort study
Blood advances · 2025
Evaluating the Impact of an Institutional Practice Change from Warfarin to Therapeutic Rivaroxaban Post-Fontan Operation.
Pediatric cardiology · 2025 · first author

All 10 publications

10 publications.

Early venous thrombus resolution in neonates/infants: retrospective review of a 20-year single institution experience.

Yan E, Bauman M, Meakins L, Bruce A, Livingston J

Research and practice in thrombosis and haemostasis2026Senior author

DOI: 10.1016/j.rpth.2026.103455 PMID: 42027318

Critical bleeding in adults and children with immune thrombocytopenia: a multicenter cohort study

Sirotich E, Chowdhury SR, Modi D, Guyatt G, St John M, Eisa K, Cuker A, Beck CE, Grace RF, Yan JW

Blood advances20254 citationsOpen Access

DOI: 10.1182/bloodadvances.2024015494

Evaluating the Impact of an Institutional Practice Change from Warfarin to Therapeutic Rivaroxaban Post-Fontan Operation.

Livingston J, Meakins L, Conway J, Ash A, Eckersley L, Bauman M

Pediatric cardiology2025First author

DOI: 10.1007/s00246-025-04137-4 PMID: 41442051

EKITE phase 2: A valuable readily available resource for patient education on thrombosis and warfarin anticoagulation therapy.

Bauman M, Bhat R, Hagtvedt R, Livingston J, Bruce A

Thrombosis research2025

DOI: 10.1016/j.thromres.2025.109322 PMID: 40318475

Rapid Enoxaparin Adjustment for Childhood Thrombosis/Thromboprophylaxis.

Livingston J, Meakins L, Bruce A, Stammers D, Corriveau-Bourque C, Serebrin A, Wong K, Bauman M

Pediatric blood & cancer2025First author

DOI: 10.1002/pbc.31691 PMID: 40186456

Face validity of the Kids’ ITP Tools (KIT) in the era of thrombopoietin receptor agonists

Catherine McGuire, Nancy Lynn Young, Joel Livingston, Vinita Dhir, Victor S. Blanchette, Melanie Ann Kirby-Allen, Robert J. Klaassen

Pediatric Blood & Cancer20243 citations

DOI: 10.1002/pbc.30888 PMID: 38265264

Pediatric eosinophilic granulomatosis with polyangiitis and intracardiac thrombus: A case report

Katharine V. Jensen, Nicholas Brochez, Christopher M. Spence, Joel Livingston, Michael Khoury, Jeanine McColl

SAGE Open Medical Case Reports2024Open Access

DOI: 10.1177/2050313x241309966 PMID: 39713605

Identification of a novel MYH9-related disease-associated mutation with multiple faintly staining Döhle-like bodies.

Yin C, Turley E, Livingston J

Pediatric blood & cancer2024Senior author

DOI: 10.1002/pbc.31183 PMID: 38965687

A cost-utility analysis of thrombopoietin receptor agonists for treating pediatric immune thrombocytopenia purpura after failure of first-line therapies.

Du H, Wang J, Livingston J, Alrajhi Z, Kirby-Allen M, Chan B, Hancock-Howard R, Coyte PC

Pediatric blood & cancer2023Open Access

DOI: 10.1002/pbc.30523 PMID: 37391862

Evaluating the impact of thrombopoietin receptor agonist medications on patient outcomes and quality of life in paediatric immune thrombocytopenia through semi‐structured interviews

Joel Livingston, Ziyad Alrajhi, Melanie Jackson, Catherine McGuire, Dennis Newhook, Robert J. Klaassen, Melanie Ann Kirby-Allen

British Journal of Haematology20227 citationsFirst author

DOI: 10.1111/bjh.18545 PMID: 36345812

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Joel Livingston

Research

Latest papers

Early venous thrombus resolution in neonates/infants: retrospective review of a 20-year single institution experience.

Critical bleeding in adults and children with immune thrombocytopenia: a multicenter cohort study

Evaluating the Impact of an Institutional Practice Change from Warfarin to Therapeutic Rivaroxaban Post-Fontan Operation.

EKITE phase 2: A valuable readily available resource for patient education on thrombosis and warfarin anticoagulation therapy.

Rapid Enoxaparin Adjustment for Childhood Thrombosis/Thromboprophylaxis.

Face validity of the Kids’ ITP Tools (KIT) in the era of thrombopoietin receptor agonists

Pediatric eosinophilic granulomatosis with polyangiitis and intracardiac thrombus: A case report

Identification of a novel MYH9-related disease-associated mutation with multiple faintly staining Döhle-like bodies.

A cost-utility analysis of thrombopoietin receptor agonists for treating pediatric immune thrombocytopenia purpura after failure of first-line therapies.

Evaluating the impact of thrombopoietin receptor agonist medications on patient outcomes and quality of life in paediatric immune thrombocytopenia through semi‐structured interviews

Frequent collaborators

Robert Klaassen

Anna Serebrin

Michael Khoury

Rebecca Hancock-Howard

Carolyn Beck

Donald Arnold

Dena Zeraatkar

Gordon Guyatt

Shuoyan Ning

Peter Coyte

Jeannie Callum

Brian Chan

Nancy Young

Jeanine McColl

Jennifer Conway

Lehana Thabane

Luke Eckersley

Joel Livingston

Research

Latest papers

Early venous thrombus resolution in neonates/infants: retrospective review of a 20-year single institution experience.

Critical bleeding in adults and children with immune thrombocytopenia: a multicenter cohort study

Evaluating the Impact of an Institutional Practice Change from Warfarin to Therapeutic Rivaroxaban Post-Fontan Operation.

EKITE phase 2: A valuable readily available resource for patient education on thrombosis and warfarin anticoagulation therapy.

Rapid Enoxaparin Adjustment for Childhood Thrombosis/Thromboprophylaxis.

Face validity of the Kids’ ITP Tools (KIT) in the era of thrombopoietin receptor agonists

Pediatric eosinophilic granulomatosis with polyangiitis and intracardiac thrombus: A case report

Identification of a novel MYH9-related disease-associated mutation with multiple faintly staining D&#xf6;hle-like bodies.

A cost-utility analysis of thrombopoietin receptor agonists for treating pediatric immune thrombocytopenia purpura after failure of first-line therapies.

Evaluating the impact of thrombopoietin receptor agonist medications on patient outcomes and quality of life in paediatric immune thrombocytopenia through semi‐structured interviews

Frequent collaborators

Robert Klaassen

Anna Serebrin

Michael Khoury

Rebecca Hancock-Howard

Carolyn Beck

Donald Arnold

Dena Zeraatkar

Gordon Guyatt

Shuoyan Ning

Peter Coyte

Jeannie Callum

Brian Chan

Nancy Young

Jeanine McColl

Jennifer Conway

Lehana Thabane

Luke Eckersley

Identification of a novel MYH9-related disease-associated mutation with multiple faintly staining Döhle-like bodies.